HCEMM logo

In partnership with

EMBL logo

In partnership with

EMBL logo

Presentations

ORAL PRESENTATIONS

    2021

  1. Zsuzsanna Darula Development of a laser dissection-coupled quantitative microlipidomic method to resolve tumor heterogeneity.Vanda Varga-Zsíros, Mária Péter, Ede Migh, Annamária Marton, Imre Gombos, Barbara Dukic, Zoltán Kóta, Péter Horváth, László Tiszlavicz, Csaba Vizler, Zsolt Török, László Vígh, Gábor Balogh.  International Conference on the Bioscience of Lipids (Netherlands)
  2. Zsuzsanna Darula FAIMS – proteomikai alkalmazások. Éva Klement. MS Szakmai Nap, (online).
  3. Zsuzsanna Darula Világossejtes veserák és normál vese transzkriptom és proteom szintű célzott elemzése. Bartha Áron, Darula Zsuzsanna, Klement Éva, Munkácsy Gyöngyi, Nyirády Péter, Győrffy Balázs. XXXIV. MOT Kongresszus, Szeged (Hungary).
  4. Zsuzsanna Darula Bartha Áron, Darula Zsuzsanna, Klement Éva, Munkácsy Gyöngyi, Nyirády Péter, Győrffy Balázs: Normál és világossejtes vesedaganat proteom és transzkriptom szintű célzott elemzése. MOT Fiatal Onkológusok Szekciójának X. Konferenciája –Budapest, Hungary (in Hungarian)
  5. Attila Gácser: Investigation of the interaction between Candida extracellular vesicles and oral squamous cell carcinoma cell lines Éva Veres
  6. András Dinnyés Regenerative medicine solutions for type 1 diabetes: The iNanoBit project. Paper presented at the BIOCEV Regeneration 1, BIOCEV, Vestec, Czech Republic.
  7. András Dinnyés New approach methods (NAMs) for developmental neurotoxicology using human iPSC-derived 2D and 3D neuronal models. Paper presented at the Webinar Series: "Advanced Organotypic Models for Toxicological Screening''.

    8. 2020

  8. András Dinnyés Commercialization. Paper presented at the EU-ToxRisk meeting Egmond aan Zee, The Netherlands.
  9. András Dinnyés Human Pluripotent Stem Cell (hiPSC) based technology platform for disease modeling, toxicology and regenerative medicine applications. Paper presented at the University of Szeged, Faculty of Science and Informatics, Institute of Biology, Szeged, Hungary.
  10. András Dinnyés Őssejt-kutatás:lehetőségek, remények és korlátok-kerekasztal beszélgetés. Paper presented at the UNISTEM-NAP, Budapest, Hungary.
  11. András Dinnyés Progress in regenerative medicine using biotechnological methods for porcine islet and human beta-cell generation to treat Type-1 diabetes. Paper presented at the First Winter School „Animal Biotechnology, Nitra, Slovakia.
  12. András Dinnyés Meggyógyítható-e az egyes típusú cukorbetegség? Etikai és szabályozási dilemmák emberi őssejtek és sertés hasnyálmirigy sejtek beültetése kapcsán. Paper presented at the Elég fejlettek vagyunka fejlett terápiákhoz? Tudományos tájékoztató ülés a fejlett terápiák alkalmazási lehetőségeiről, Budapest, Hungary.
  13. Karolina Pircs: European Researcher's Night (Kutatók éjszakája a virtuális térben)
  14. Roland Tengölics [Balázs Papp's group member]: Accelerated metabolome evolution of cerevisiae, Darwin Days, Tihany, 11-13/02/2020, presentation
  15. Eszter Ari [Balázs Papp's group member]: Microbiome test methods and interpretation of result, MGT Colon Section, Visegrád, 06-07/03/2020, presentation Download (Hungarian)
  16. László Csanády: 64th Annual Meeting of the Biophysical Society 2020: https://biophysics.cld.bz/Biophysical-Society-2020-Annual-Meeting/42/ https://biophysics.cld.bz/Biophysical-Society-2020-Annual-Meeting/52/ https://biophysics.cld.bz/Biophysical-Society-2020-Annual-Meeting/154/
  17. Csaba Bödör: Molecular biomarkers in CLL in the era of targeted therapies – The laboratory perspective. International Janssen Hematology Academy, Budapest March 27-28, 2020.

    18. 2019

  18. András Dinnyés Genetikai újraprogramozás és az őssejtekkel végzett regenerációs orvoslás lehetőségei. Paper presented at the Qubit Live rendezvény, Budapest, Magyarország.
  19. András Dinnyés Genetikailag újraprogramozott őssejtek a regenerációs orvoslásban. Paper presented at the 30 éves jubileumi találkozó Pro Scientia Aranyérmesek Társasága, Budapest, Hungary.
  20. András Dinnyés Opportunities for Innovative European SMEs in China. Paper presented at the 14th EU-China Business & Technology Co-operation Fair Chengdu, China. András Dinnyés Őssejt kutatás: remények és kétségek. Paper presented at the UNISTEM-NAP Budapest, Budapest, Magyarország.
  21. András Dinnyés: Bellak, T, J. Kobolak, A. Teglasi, V. Szegedi, LM. Giudice, I. Bock, K. Molnar, L. Laszlo, D. Berki, A. Dinnyes. 2019, Modelling Alzheimer’s Disease with 3D Engineered Neuronal Tissue Derived from Induced Pluripotent Stem Cells. Paper presented at the 16th Annual Conference of the Hungarian Neuroscience Society, Hungarian Academy of Sciences, Debrecen, Hungary.
  22. András Dinnyés Academician of EU Academy of Science. Paper presented at The 14th EU-China Business and Technology Cooperation Fair and EU-China New Economy and Free Trade Forum, Chengdu, China.
  23. András Dinnyés Alzheimer disease: With mini brain models towards healing. Paper presented at the European Researcher's night, Budapest, Hungary.
  24. András Dinnyés Humán őssejt-alapú technológiai platform szolgáltatások gyógyszerfejlesztési-, toxikológiai- és regenerációs medicina célok érdekében. Paper presented at the Magyar Biotechnológiai Szövetség Partnertalálkozó. Budapest, Hungary.
  25. András Dinnyés Külföldieket támogató gyakorlatok. Paper presented at the Nehezített pályán, avagy a magyarországi külföldi származású nők pályaújrakezdési lehetőségei műszaki-természettudományos területeken című mini-konferenciájára, Budapest, Hungary.
  26. András Dinnyés New era of health economics: Transformational power of regenerative medicine. Paper presented at the The 14th EU-China Business and Technology Cooperation Fair and EU-China New Economy and Free Trade Forum, Chengdu, China.
  27. András Dinnyés On-site one to one business discussion of domestic and foreign enterprises. Paper presented at the 2019 China (West) Belt and Road Initiative, Cross-Boarder Investment and Trade Matchmaking Event, Chongqing, China.
  28. András Dinnyés Őssejt technológiákról. Paper presented at the Kosa Erika Akademia, Budapest, Hungary.
  29. András Dinnyés. P. Bartenstein, R. Bouaoun, N. Burton, C. Cyran, P. Gianello, E. Kemter, J. Kobolak, G. Nemeth, F. Nicotra, E. Prepost, Y. Qiu, L. Russo, A. Wirth, E. Wolf, S. Ziegler. 2019. Progress with the Integration of Nano- and Biotechnology for Beta-cell and Islet Transplantation in the EU H2020 iNanoBIT project. Paper presented at the Chinese stem cell society (CSSCR) annual meeting Tianjin, China.
  30. András Dinnyés Regenerációs medicinák. Paper presented at the Embernek maradni...Az érzelmi itelligencia napja, Budapest, Magyarország.
  31. András Dinnyés Xenotranszplantáció és ember-állat kimérikus szervek a regenerációs orvoslásban: aktualitások az IXA2019 konferenciáról (München, 2019. okt. 10-13). Paper presented at the Magyar Tudományos Akadémia, Állatkísérleti Osztályközi Állandó Bizottsága (ÁOÁB) éves ülés, Budapest, Hungary.
  32. András Dinnyés, Z. Janstova, W. Xu, A. Feher, J. Kobolak, Q. Sun. The emerging need for human cell based in vitro toxicology in food safety. Paper presented at The 14th International Scientific Conference organized by the Faculty of Biotechnology and Food Sciences, Slovak University of Agriculture in Nitra, Dolné Krškany, Slovakia.
  33. András Dinnyés., J. Kobolak, E. Kemter, N. Burton, Y. Qiu, E. Prepost, A. Wirth, G. Németh, R. Bouaoun, TC. Burcez, A. Schnur, S. Muenthaisong, P. Gianello, L. Russo, F. Nicotra, C. Cyran, P. Bartenstein, S. Ziegler, E. Wolf. The iNanoBIT project: integration of Nano-and Biotechnology for Beta-cell and Islet Transplantation. Paper presented at the International Xenotransplantation Association 2019 (IXA 2019), Munich, Germany.
  34. András Dinnyés: Feher, A., Zs. Táncos, I. Bock, J. Kobolak, Zs. Turi, D. Berki, A. Dinnyes. 2019. Generation of a fluorescent reporter human iPSC line to detect oxidative stress using endogen gene tagging. Paper presented at the EU-ToxRisk Open Symposium & General Assembly, Egmond aan Zee, The Netherlands.
  35. András Dinnyés: Francistiova, L., A. Teglasi, Zs. Turi, J. Kobolak, A. Dinnyes. Modelling Alzheimer's disease progression with disease-specific human induced pluripotent stem cells Paper presented at the Cost Action, Athens, Greece.
  36. András Dinnyés Janstova, Z., J. Kobolak, M. Bodi-Jakus, A. Dinnyes. 2019. Human induced pluripotent stem cell based in vitro neurotoxicology model. Paper presented at the EU-ToxRisk Open Symposium & General Assembly, Egmond aan Zee, The Netherlands.
  37. András Dinnyés: Kobolak, J., A. Teglasi, T. Bellak, K. Molnar, I. Bock, Z. Janstova, L. Laszlo, A. Dinnyes. Establishment of a Human iPSC-based 3D-Neurosphere Assay to detect Developmental Neurotoxicity. Paper presented at the EU-ToxRisk Open Symposium & General Assembly, Egmond aan Zee, The Netherlands.
  38. András Dinnyés: Kobolak J., K. Molnar, E. Varga, I. Bock, B. Jezso, A. Teglasi, ML. Guidice, N. Varga, L. Laszlo, A. Dinnyes. Modelling the neuropathology of mucopolysaccharidosis type II with disease-specific human induced pluripotent stem cells. Paper presented at the Second CellFit Workshop 2019, Belgrade, Serbia.
  39. András Dinnyés: Kobolak, J., K. Molnar, E. Varga, I. Bock, B. Jezso, A. Teglasi, LM. Giudice, N. Varga, L. Laszlo, A. Dinnyes. 2019. Modelling the Neuropathology of Mucopolysaccharidosis Type II with Disease specific Human Induced Pluripotent Stem Cells. Paper presented at the Second CellFit Workshop Belgrade, Serbia.
  40. András Dinnyés: Kobolak, J., A. Teglasi, T. Bellak, K. Molnar, I. Bock, Z. Janstova, L. Laszlo, A. Dinnyes. Human iPSC derived 3D-neurosphere assay to study developmental neurotoxicity. Paper presented at the International Society for Stem Cell REsearch Anual meeting (ISSCR), Amsterdam, The Netherlands.
  41. András Dinnyés: Teglasi, A., J. Kobolak, T. Bellak, K. Molnar, I. Bock, Z. Janstova, L. Laszlo, A. Dinnyes. Efficient Developmental Neurotoxicity Method Using a Human iPSC Derived 3D-neurosphere Assay. Paper presented at the EuToxRisk Commersialization meeting, Basel, Switzerland.
  42. Kintses Bálint: Phylogenetic barriers to horizontal transfer of antimicrobial peptide resistance genes in the human gut microbiome. Gordon Research conference
  43. Ferhan Ayaydin: Biotechnology Conference, Baskent University, Turkey: “From Gene Editing to Bacterial Sensors: Fluorescence Imaging as a Versatile Tool” Invited speaker
  44. Karolina Pircs: 2nd Nordic Huntington Disease Research Meeting, Lund, Sweden (oral presentation)
  45. Karolina Pircs: EMBO Workshop, Autophagy: From molecular principles to human diseases, Crieff, Scotland, UK (poster presenation)
  46. Karolina Pircs: The Segerfalk Symposium & Neuroscience Day, Lund, Sweden (chair and oral presentation)
  47. Bálint Kintses : Phylogenetic barriers to horizontal transfer of antimicrobial peptide resistance genes in the human gut
  48. Nikolett Wohner: Gordon Research conference, 2019
  49. Bertalan Vilmos Takács, Lajos Haracska: Our inner world the microbiome (in Hungarian) , Szent-Györgyi Albert Camp, 2020
  50. Lajos Haracska: Engines of mutagenesis and carcinogenegesis; replication of damaged DNA, The 9th Conference of the Serbian Biochemical Society
  51. Lajos Haracska: The speed factor: engines of cancer and aging , Straub Days, 2019
  52. Lajos Haracska: Engines of carcinogenesis; what determines the speed of mutagenesis? Hungarian Molecular Life Sciences 2019, Eger
  53. Zoltan V. Varga, Zsofia Onodi, Mihaly Ruppert, Przemyslaw Leszek, Viktoria Eva Toth, Gabor Koncsos, Tamas Radovits, Peter Ferdinandy , Inflammasome activation in chronic heart failure ,  Straub days ,Szeged, Magyarország; 2019. May
  54. Zoltan V. Varga, Katalin Erdelyi, Uwe Grether, Eszter Trojnar, Catarina Raposo, Jürgen Fingerle, Christoph Ullmer, Ozge Gunduz-Cinar, Michelle Glass, Bela Szabo, Miklos Palkovits, Andrew Holmes,Jürg Gertsch, Julian Romero, Cecilia Hillard and Pal Pacher Cannabinoid 2 receptor (cb2) expression revisited: Detection of CB2 mRNA with new sensitive tools, Congress of the International Cannabinoid Research Society, Bethesda, MD., USA; 2019. June
  55. Zoltan Varga, Angela Kecskes Advantages, disadvantages and potential pitfalls of RNAscope multiplex fluorescent in situ hybridization 3rd COST Action CardioRNA working group meeting  Isztanbul, Törökország; 2019. Oct
  56. Balázs Enyedi: Hungarian Academy of Sciences – MTA-TTK
  57. Domokos Máthé: Radioisotope Molecular Imaging in Cancer Therapy
  58. Domokos Máthé: Imaging metabolism and inflammatory response in mouse heart ischaemia using three modalities (SPECT, PET and cMRI),
  59. Paras Gaur, Lajos Haracska : Small molecule inhibitors of PCNA ubiquitination and post replication repair, Central European Genome Stability and Dynamics Meeting, 2019, Bratislava
  60. Lajos Haracska: DNA damage repair PhD course (Nov. 2018)
  61. Lajos Haracska: Development of DNA sequencing (March 2018), University of Szeged, course for BSc, MSc, and PhD
  62. Alexandra Gráf, Lajos Haracska: Single yeast colony mutagenesis screen based on next-generation sequencing , Straub Days, 2018
  63. Csaba Bödör : Dissection of subclonal evolution by temporal mutation profiling in chronic lymphocytic leukemia patients treated with ibrutinib. Annual Meeting of the Society of Hematologic Oncology, Houston, USA, September 11-14, 2019.
  64. Csaba Bödör: Risk stratification in CLL: integrated approaches. Educational meeting: Precision medicine in CLL: what is the role of immunoglobulin gene analysis?, Paris, July 4-5, 2019.
  65. Csaba Bödör: EZH2 gain-of-function mutations are not associated with more favorable prognosis in relapsed/refractory follicular lymphoma: a preliminary analysis on 590 patients. 23rd Congress of European Hematology Association, Amsterdam, June 13-16, 2019.
  66. Csaba Bödör: Modern Molecular Diagnostics of CLL- State of The Art (2019). Janssen Hematology Academy: Redefining Treatment paradigms, Budapest, April 12-13, 2019.
  67. Csaba Bödör: Germline disease testing: Germline material-which sources. 32nd Annual EWOG-MDS working group meeting. Frankfurt, June 18-20, 2018.

    68. 2018

  68. András Dinnyés: Bourguignon, A., I. Bock, A. Feher, J. Kobolak, A. Dinnyes. Development of a cellular toxicology model using genetically engineered human induced pluripotent stem cells, a 3Rs alternative to animal testing. Paper presented at the CEELA IV. Central and Eastern European Laboratory Animal Triannual Conference, Budapest, Hungary.
  69. András Dinnyés: Bourguignon, A., I. Bock, A. Feher, J. Kobolak, A. Dinnyes. Development of a cellular toxicology model using genetically engineered human induced pluripotent stem cells. Paper presented at The 20th International Congress on In Vitro Toxicology, ESTIV, Berlin, Germany.
  70. András Dinnyés: Bourguignon, A., J. Kobolak, Z. Janstova, I. Bock, A. Feher, A. Dinnyes. Development of a cellular neurotoxicology model using genetically engineered human induced pluripotent stem cells, a 3Rs alternative to animal testing. Paper presented at the EUSAAT 2018, Linz, Austria.
  71. András Dinnyés. Humán pluripotens őssejt technológiai platform a betegség modellezés, toxikológia és regenerációs medicina területein. Paper presented at the II. Sejt-, Fejlődés és Őssejbiológusok éves találkozója c. minikonferencia, Budapest, Hungary.
  72. András Dinnyés Modelling sporadic Alzheimer's disease using patient derived iPSCs. Paper presented at the Eusaat, Linz, Austria.
  73. András Dinnyés: Bourguignon A., I. Bock, A. Feher, J. Kobolak, A. Dinnyes. 2018. Development of a cellular toxicology model using genetically enginieered human induced pluripotent stem cells. Paper presented at The 20th International Congress on In Vitro Toxicology (ESTIV 2018), Berlin, Germany.
  74. András Dinnyés: Bourguignon, A., A. Feher, I. Bock, J. Kobolak, A. Dinnyes. Endogenous tagging of human induced pluripotent stem cells (iPSCs) using the CRISPR/Cas9 genome editing technique. Paper presented at the XVII. Genetikai Műhelyek Magyarországon Minikonferencia, Szeged, Hungary.
  75. András Dinnyés: Chandrasekaran, A., HX. Avci, A. Ochaleka, LN. Rösingh, K. Molnar, L. Laszlo, T. Bellak, A. Teglasi, K. Pesti, A. Mike, P.      Phanthong, O. Biro, V. Hall, N. Kitiyanant, KH. Krause, J. Kobolak, A. Dinnyes. Comparison of 2D and 3D neural induction methods for the generation of neural progenitor cells from human induced pluripotent stem cells. Paper presented at the IV. Nemzetközi Interdiszciplináris 3D Konferencia és Szakmai Kiállítás, Pécs, Hungary.
  76. András Dinnyés: Chandrasekaran, A., HX. Avci, A. Ochaleka, LN. Rosingh, K. Molnar, L. Laszlo, T. Bellak, A. Teglasi, K. Pesti, A. Mike, P.      Phanthong, O. Biro, V. Hall, N. Kitiyanant, KH. Krause, J. Kobolak, A. Dinnyés. In vitro modelling of the human central nervous system: 2D and 3D neural induction methods for the generation of neural progenitor cells from human induced pluripotent stem cells. Paper presented at the IV. Nemzetközi Interdiszciplináris 3D Konferencia és Szakmai Kiállítás, Pécs, Hungary
  77. András Dinnyés. Mesterséges szövetek és szervek őssejtekből – a regeneraciós orvoslás lehetőségei. Paper presented at the Magyar Tudomány Ünnepe, Budapest, Hungary.
  78. András Dinnyés Őssejt-kutatás: remények és kétségek, kerekszasztal beszélgetés. Paper presented at the UNISTEM-NAP Budapest, Budapest, Hungary.
  79. András Dinnyés, Advanced in vitro cell models for neurotoxicity studies. Paper presented at the BIONECA COST Action meeting, Malta.
  80. András Dinnyés: Francistiova, L., J. Kobolak, A. Dinnyes. ALZHEIMER KÓR: Mini-agy modellekkel a gyógyítás felé. Paper presented at the Kutatók Éjszakája, Budapest, Hungary.
  81. András Dinnyés: Giudice, ML., B. Mihalik, J. Kobolak, D. Riccardi, JP. Kemp, A. Dinnyes. Expression of the Calcium sensing receptor (CaSR) in neuronal cultures generated from healthy and familial Alzheimer’s disease iPSCs. Paper presented at the Federation of European Neuroscience Societies (FENS), Berlin, Germany.
  82. András Dinnyés, ML. Giudice, A. Bourguignon, L. Francistiova, J. Kobolak. Providing Human Stem Cell Technology Solutions. Paper presented at the BIONECA Cost Action Meeting, Malta.
  83. András Dinnyés., Z. Janstova, B. Mihalik, M. Bodi-Jakus, J. Kobolak. Human induced pluripotent stem cell based in vitro neurotoxicology model. Paper presented at The 20th International Congress on In Vitro Toxicology, ESTIV, Berlin, Germany.
  84. András Dinnyés: Kobolak, J. O., A. Chandrasekaran, A. Bellák, T. Teglasi, A. Molnar, K. Schmidt, B. Szegedi, V. Bock, I. Laszlo, L. Dinnyes, A., 3D Engineered Neural Tissue from Induced Pluripotent Stem Cells as a Tool for Modelling Diseases, Testing Drugs or Neurotoxicity. Paper presented at the EU-ToxRisk General Assembly, Egmond aan Zee, The Netherlands.
  85. András Dinnyés: Ochalek, A. M., B. X. Avci, H. Chandrasekaran, A. Teglasi, A. Bock, I. Giudice, ML. Tancos, Zs. Molnar, K. Laszlo, L. E. Nielsen, J. Holst, B. Freude, K. Hyttel, P. Kobolak, J. Dinnyes, A. Neurons derived from sporadic Alzheimer’s disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels and GSK3B activation. Paper presented at the Gyógyszer Innováció Konferencia, Velence, Hungary.
  86. Enyedi Balázs: Semmelweis University – Research Salon (invited speaker)
  87. Kintses Bálint: Phylogenetic barriers to horizontal transfer of antimicrobial peptide resistance genes in the human gut microbiome. Sixth International Symposium on Antimicrobial Peptides, Poitiers, France
  88. Fehan Ayaydin: >Hungarian Microscopy Association Meeting, Siofok, Hungary: “Use of Fluorescence Microscopy and Mutant Green Fluorescent Protein in Plant Gene Editing”- (Speaker)
  89. Ferhan Ayaydin: Future Research Challenges – Hungarian-Norwegian Conference, Budapest, Hungary. “Improving Biomass Productivity, CO2 Uptake and Pest/Pathogen Resistance of Short Rotation Energy Willow and Poplar by Polyploidy and Heterosis: Genome Optimization” (Speaker)
  90. Karolina Pircs: NECTAR, Paris, France (oral presentation)
  91. Karolina Pircs: Nordic Huntington Disease Research Meeting, Lund, Sweden (oral presentation)
  92. Nikolett Wohner: VIII. Multiple Myeloma Congress, Lillafüred, Hungary)Zoltan V. Varga, Katalin Erdelyi, Resat Cinar, Raphael Mechoulam, George Kunos and Pal Pacher
  93. Zoltan V. Varga, Katalin Erdelyi, Resat Cinar, Raphael Mechoulam, George Kunos and Pal Pacher The selective CB2-R agonist, HU-910 attenuates hepatorenal syndrome development in a mouse model of liver failure Congress of the International Cannabinoid Research Society, Leiden, Hollandia; 2018. Június
  94. Zoltán Varga, Pacher P, Az endokannabinoid rendszer változásainak molekuláris és transzlációs vizsgálata a szívben kóros elhízás során.  Magyar Farmakológusok Társaságának Éves Kongresszusa Velence, Magyarország; 2018. April
  95. Zoltán Varga, Pacher P. Az arginin anyagcsere és a nitrogén monoxid szintézis zavara a hepatorenális szindróma patogenezisében. Magyar Tudomány Ünnepe. Budapest, Magyarország; 2018. November
  96. Balázs Enyedi: Semmelweis University – Research Salon
  97. Domokos Máthé, N Hegedűs, DS Veres, I Horváth, MJ Vicenc Bonet, K Szigeti, Intracranial glioblastoma follow-up study by multimodal imaging methods, Le Bono, France, 2018. 09. 26-29.
  98. Domokos Máthé, G Taba, L Harsányi, Á Balázs Clinical trial dosimetry results of 18F-FDG application with a positron image guided cancer surgery medical device, ESRAH, Japan, 2018. Sep.
  99. Domokos Máthé, N Hegedűs, L Forgách, F Budán, DS Veres, K Szigeti, N Kovács, P Padmanabhan, M Babos, B Gulyás, Thallium labelled citrate coated Prussian Blue nanoparticles as potential imaging agent, PSMR, Isola d’Elba, Italy, 2018. 05. 21-23.
  100. Qiuzhen Li, Lajos Haracska: Fan1 acts on ICL Repair at stalled Replication fork , GINOP-2.3.2-15-2016-00020 Symposium, 2018, Debrecen
  101. Paras Gaur, Lajos Haracska: PCNA Orchestrates the DNA Damage Tolerance Pathway, Annual Conference of the  Doctoral School of Biology and UNKP Conference, 2018
  102. Mórocz Mónika, Lajos Haracska: iChamber in DNA repair and Cell Biology, GINOP-2.3.2-15-2016-00026, 2018, Hajdúszoboszló
  103. Lajos Haracska: Molecular cancer research and targeted therapy: two steps forward, one step back? (in Hungarian) Straub Days, 2017

    104. 2017

  104. András Dinnyés Neuronal differentiation of human pluripotent stem cells lines. Paper presented at the Development of human immortalized and induced pluripotent stem cells for in vitro disease modelling and toxicity testing, EUTOXRISK Bratislava, Czech Republic.
  105. András Dinnyés: Chandrasekaran, H., H. Avci, A. Ochalek, K. Molnar, L. Laszlo, T. Bellak, K. Pesti, A. Mike, J. Kobolak, A. Dinnyes. Comparison of 2D and 3D neural induction methods for the generation of neural progenitor cells (NPCS) from human iPSCs. Paper presented at the A Magyar Kísérletes és Klinikai Farmakológiai Társaság Gyógyszerinnovációs Kongresszusa, Velence, Hungary.
  106. András Dinnyés: Bellak T, A. Teglasi, A. Ochalek, A. Chandrasekaran, Zs. Táncos, V. Szegedi, J. Kobolak, A. Andras. Three-dimensional Engineered Neural Tissues (ENTs) in Modelling Neurological Diseases. Paper presented at the First Annual Meeting, COST Action CA16119 CellFit, In vitro 3-D total cell guidance and fitness, Bulgaria.
  107. András Dinnyés: Berzsenyi, S., J. Nagy, J. Kobolak, Z. Abraham, H. Avci, I. Bock, B. Hodoscsek, E. Tarnokne Voros, Z. Bekes, A. Chandrasekaran, A. Ochalek, E. Varga, C. Nemes, B. Kovanyi, P. Dezso, T. Szel, L. Fodor, K. Nemeth, A. Balazs, A. Dinnyes, G. Levay, B. Lendvai, V. Roman. 2017. Establishment of a hiPSC-based neural model of Kleefstra Syndrome associated with autism. Paper presented at the International Society for Stem Cell Research (ISSCR), Boston, USA.
  108. András Dinnyés. Comparison of 2D and 3D neural induction methods for the generation of neural progenitor cells (NPCS) from human iPSCs. Paper presented at the Hungarian Molecular Life Sciences, Hotel Eger & Park. Eger, Hungary.
  109. András Dinnyés Testre-szabható betegség modell rendszerek fejlesztése indukált pluripotens őssejtekkel. Paper presented at the A Magyar Kísérletes és Klinikai Farmakológiai Társaság Gyógyszerinnovációs Kongresszusa, Velence, Hungary.
  110. András Dinnyés Neuronal differentiation of human pluripotent stem cells lines. Paper presented at the Congress of the European Societies of Toxicology, Bratislava, Slovakia.
  111. András Dinnyés A. Chandrasekaran, H. Avci, A. Ochalek, K. Molnár, L. László, T Bellák, K. Pesti, A. Mike, J. Kobolák. Comparison of 2D and 3D human iPSCs neural induction methods for the generation of neural progenitor cells (NPCs). Paper presented at the The Next Generation, an ISSCR International Symposium, Guanzgzou China.
  112. András Dinnyés, J. Kobolak. Idegrendszeri betegség és toxicitási modellek fejlesztése pluripotens őssejtek segítségével. Paper presented at the Bio-Science Kft. Tudományos Napja, Budapest, Larus Rendezvényközpont.
  113. András Dinnyés: Kobolak, J., B. Mihalik, A. Teglasi, W. Xu, Q. Sun, A. Dinnyes. Human in vitro neurotoxicology enabled by hiPSC-derived neurons. Paper presented at the 45th annual meeting of European Teratology Society, Budapest, Hungary.
  114. András Dinnyés: Kobolak, J., B. Mihalik, A. Teglasi, W. Xu, Q. Sun, A. Dinnyes. Human induced pluripotent stem cell based in vitro neurotoxicology model. Paper presented at the Federation of European Neuroscience Societies (FENS), Pécs Hungary.
  115. András Dinnyés: Giudice, ML., B. Mihalik, J. Kobolak, A. Dinnyés. Studies on the role of the CaSR in human iPSC-derived neuronal cells. Paper presented at the Federation of European Neuroscience Societies (FENS), Pécs, Hungary.
  116. András Dinnyés: Mihalik, B., B. Francz, A. Teglasi, Q. Li, QSW Xu, J. Kobolak, A. Dinnyes. Human induced pluripotent stem cell (hiPSC)-based in vitro neurotoxicology models. Paper presented at the Hungarian Experimental and Clinical Pharmacology Society Pharma-innovation Conference (Magyar Kísérletes és Klinikai Farmakológiai Társaság Gyógyszerinnovációs Kongresszusa), Velence, Hungary.
  117. András Dinnyés: Roman V., S. Berzsenyi, J. Kobolák, Z. Abraham, XH. Avci, I. Bock, B. Hodoscsek, E. Tárnokné Vörös, Z. Bekes, A. Chandrasekaran, A. Ochalek, E. Varga, Cs. Nemes, B. Koványi, P. Dezső, T. Szél, L. Fodor, K. Nemeth, A. Balázs, A. Dinnyés, G. Levay, B. Lendvai, J. Nagy. Establishment of a human induced pluripotent stem cell-based model of Kleefstra syndrome. Paper presented at the International Meeting for Autism Research (IMFAR) San Francisco, California, USA.
  118. András Dinnyés: Szantai, A., J. Paloczi, E. Ruivo, R. Gaspar, A. Dinnyes, A. Investigating the influence of mild oxidative stress to ischemic sensitivity of cardiomyocytes differentiated from mouse embryonic stem cell and induced pluripotent stem cell origin.
  119. Enyedi Balázs: IST Vienna, Life Sciences Semainar (invented speaker)
  120. Karolina Pircs: Multipark Retreat: Highlighting the use of Multipark infrastructure, Lund, Sweden (oral presentation, Cellomics Platform)
  121. Karolina Pircs: EMBO Autophagy: From molecular principles to human diseases, Dubrovnik, Croatia (selected abstract oral presenation)
  122. Balázs Enyedi: IST Vienna, Life Sciences Semainar
  123. Domokos Máthé, K Szigeti, Sz Osváth, K Nagy, G Németh, A vaszkularizáció in vivo képalkotása és parametrizálása nanorészecske kontrasztanyagok segítségével, MTÜ NSZP szimpózium, Budapest, Magyarország, 2017.11.03-30.
  124. Domokos Máthé, N Hegedűs, N Kovács, K Szigeti, I Horváth, DS Veres, M Bachmann, R Bergmannm,Monitoring possibilities of external beam radiotherapy using MRI-PET multi-modal imaging technique Prediction and modeling of response to molecular and external beam radiotherapies, Le Bono, France, 2017. 09. 20-23.
  125. Domokos Máthé, M Occhipinti, M Carminati, GL Montagnani, K Nagy, G Légrádi, Z Nyitrai, A Kühne, C Fiorini, Development and preliminary results of a preclinical SPECT/MR insert, PSMR, Lisbon, Portugal, 2017. 05. 29-31.
  126. Domokos Máthé: Molecular Imaging – SPECT, PET, MRI and optical methods, Radiokémia és képalkotás szimpózium, Krakkó, Lengyelország, 2017. 03.24.
  127. Mónika Mórocz, Lajos Haracska: SPARTAN regulates replication of DNA-protein crosslink-containing DNA, protects against premature aging and cancer, Hungarian Molecular Life Science 2017, Eger
  128. Csaba Bödör : JAK/STAT pathway aberrations in RUNX1 mutated patients. 60th ASH American Society of Hematology Annual Meeting & Exposition, Atlanta, USA, December 1-4, 2017.
  129. Csaba Bödör : Cell of Origin and Genomic Profile of Primary Central Nervous System Lymphoma Determined Using the Nanostring LST Assay and Ultra Deep Targeted Next Generation Sequencing. 60th ASH American Society of Hematology Annual Meeting & Exposition, Atlanta, USA, December 1-4, 2017.
  130. Csaba Bödör :Dissection of Clonal Evolution by Temporal Mutation Profiling in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib. 60th ASH American Society of Hematology Annual Meeting & Exposition, Atlanta, USA, December 1-4, 2017.
  131. Csaba Bödör : The Hungarian Hairy cell Leukemia experience.Hairy cell leukemia foundation annual conference, Columbus, Ohio, USA, October 20-21, 2017.
  132. Csaba Bödör : Identification on novel biomarkers in B-cell lymphomas using next generation sequencing. 1st China- CEEC Hospital Cooperation Alliance Membership Assembly, Northern Jiangsu People's Hospital, YangZhou, China, April 21-26, 2017.

    133. 2016

  133. Karolina Pircs: Transautophagy Annual Conference, Warsaw, Poland
  134. Karolina Pircs: BAGADILICO Retreat, Ystad, Sweden
  135. Karolina Pircs: EMBO Laboratory Management Course (course): The art of leadership- fewer conflicts, more results, Heidelberg, Germany
  136. Balázs Enyedi: Mechanobiology Session of the Biophysical Society Meeting, Los Angeles, USA
  137. Domokos Máthé ,Zoltán Varga, R Dóczi, K Szigeti, I Horváth, DS Veres,  M Roller, A Morgenroth, N Bornwasser, U Königs, A Vogg : Development of a theranostic liposomal drug delivery system for radionucleosides , RANC, Budapest, Hungary, 2016. 04. 10-15.

Virtual PRESENTATIONS

    2021

  1. András Dinnyés: CEU – online conference presentation https://www.youtube.com/watch?v=2Vam_NY6AAg

    2. 2020

  2. Karolina Pircs: NECTAR virtual meeting
  3. Orsolya Liska [Balázs Papp's group member]: TFLink, a comprehensive transcription factor-target gene database,
  4. Hungarian Society for Bioinformatics, Bioinformatics 2020 virtual conference, 25 Nov 2020, presentation
  5. Balázs Papp: Evolutionary principles of antimicrobial peptide resistance, presentation, 10th Annual Meeting of the Nordic EMBL Partnership for Molecular Medicine, online, 22-25 Sept 2020, Download

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 739593. HCEMM supported by EU Programme: H2020-EU.4.a. – Teaming of excellent research institutions and low performing RDI regions. Project starting date was 1 April 2017.

EU Flag

Consortium

Semmelweis University logo
SZTE logo
BRC logo
National Research, Development and Innovation Office

About HCEMM

Hungarian Centre of Excellence for Molecular Medicine is a strong catalyst of reformative changes in biomedical science and in institutional research management.

National VAT number: 26307383-2-06
EU VAT number: HU26307383

kozadattar logo

Internal Policies

Contact Info

Copyright © 2022 Hungarian Centre of Excellence for Molecular Medicine, all rights reserved. Hungarian Centre of Excellence for Molecular Medicine® and HCEMM® are registered trademarks of the the HCEMM Nonprofit Ltd.
This website uses cookies. For more information visit the Cookies & Privacy Policy page.
ACCEPT